{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:43:50Z","timestamp":1793835830108,"version":"4.6.1"},"reference-count":68,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Environmental exposures, such as per-and polyfluoroalkyl substances (PFAS), are suspected to play a role in the significant increase in incidence of some early-onset cancers. PFAS are chemicals of concern due to their persistence in the environment, long biological half-lives, and potential carcinogenic properties. Exposure during sensitive windows of development may exert durable effects on cancer-related biological pathways leading to greater risks of early-onset cancers. This review summarizes the current evidence of PFAS exposure and early-onset carcinogenesis, with an emphasis on potential exposure routes, early-onset cancer development in humans linked with PFAS exposure, and mechanistic pathways. Emerging evidence supports a potential role for PFAS exposure in carcinogenesis during early life, particularly through prenatal and early postnatal windows of susceptibility. While epidemiologic studies increasingly link PFAS to several types of cancer, the evidence specifically addressing early-onset cancers remains limited and heterogeneous. Future research should prioritize prospective, longitudinal cohort studies with repeated exposure measurements spanning prenatal, infancy, and childhood periods, coupled with long-term follow-up into early adulthood to capture early-onset cancer outcomes.<\/jats:p>","DOI":"10.1093\/carcin\/bgag051","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:41:56Z","timestamp":1785498116000},"source":"Crossref","is-referenced-by-count":1,"title":["Exposure to per-and polyfluoroalkyl substances and early-onset cancers"],"prefix":"10.1093","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0568-7388","authenticated-orcid":false,"given":"Maaike","family":"van Gerwen","sequence":"first","affiliation":[{"name":"Department of Otolaryngology\u2014Head and Neck Surgery, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, New York, NY 10029 ,","place":["United States"]},{"name":"Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai , 1425 Madison Avenue, New York, NY 10029 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3882-1459","authenticated-orcid":false,"given":"Mathilda","family":"Monaghan","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2014Head and Neck Surgery, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, New York, NY 10029 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7875-8502","authenticated-orcid":false,"given":"Alexandra","family":"Boni","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Endocrinology, Icahn School of Medicine at Mount Sinai , New York, NY 10029 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2656-7981","authenticated-orcid":false,"given":"Melissa","family":"Florentino Puello","sequence":"additional","affiliation":[{"name":"Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai , 1425 Madison Avenue, New York, NY 10029 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3493-7419","authenticated-orcid":false,"given":"Lauren M","family":"Petrick","sequence":"additional","affiliation":[{"name":"Department of Environmental Medicine, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, New York, NY 10029 ,","place":["United States"]},{"name":"The Bert Strassburger Metabolic Center, Sheba Medical Center , Tel-Hashomer 52621 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8935-9332","authenticated-orcid":false,"given":"Angela M","family":"Leung","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, 11301 Wilshire Blvd (111D), Veterans Affairs Greater Los Angeles Healthcare System , Los Angeles, CA 90073 ,","place":["United States"]},{"name":"Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, 100 Medical Plaza Suite 310, University of California Los Angeles David Geffen School of Medicine , Los Angeles, CA 90095 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"2026093009394949000_bgag051-B1","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/s41571-022-00672-8","article-title":"Is early-onset cancer an emerging global epidemic? Current evidence and future implications","volume":"19","author":"Ugai","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"2026093009394949000_bgag051-B2","volume-title":"Examining the Rise of Early-Onset Incidence Across Cancer Types","author":"Matthius"},{"key":"2026093009394949000_bgag051-B3","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1158\/2159-8290.CD-24-1678","article-title":"Trends in cancer incidence and mortality rates in early-onset and older-onset age groups in the United States, 2010\u20132019","volume":"15","author":"Shiels","year":"2025","journal-title":"Cancer Discov"},{"key":"2026093009394949000_bgag051-B4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jncc.2022.08.005","article-title":"Cancer overdiagnosis: a challenge in the era of screening","volume":"2","author":"Dunn","year":"2022","journal-title":"J Natl Cancer Cent"},{"key":"2026093009394949000_bgag051-B5","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nrendo.2016.110","article-title":"The changing incidence of thyroid cancer","volume":"12","author":"Kitahara","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"2026093009394949000_bgag051-B6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S1470-2045(23)00622-8","article-title":"Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid","volume":"25","author":"Zahm","year":"2024","journal-title":"Lancet Oncol"},{"key":"2026093009394949000_bgag051-B7","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1289\/ehp.1306615","article-title":"Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant","volume":"121","author":"Barry","year":"2013","journal-title":"Environ Health Perspect"},{"key":"2026093009394949000_bgag051-B8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41370-024-00742-2","article-title":"Associations between per-and polyfluoroalkyl substances (PFAS) and county-level cancer incidence between 2016 and 2021 and incident cancer burden attributable to PFAS in drinking water in the United States","volume":"35","author":"Li","year":"2025","journal-title":"J Expo Sci Environ Epidemiol"},{"key":"2026093009394949000_bgag051-B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104831","article-title":"Per-and polyfluoroalkyl substances (PFAS) exposure and thyroid cancer risk","volume":"97","author":"van Gerwen","year":"2023","journal-title":"EBioMedicine"},{"key":"2026093009394949000_bgag051-B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2024.119909","article-title":"Perfluoroalkyl substances exposure and the risk of breast cancer: a nested case-control study in Jinchang cohort","volume":"262","author":"Dou","year":"2024","journal-title":"Environ Res"},{"key":"2026093009394949000_bgag051-B11","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1093\/jnci\/djaa143","article-title":"Serum concentrations of per-and polyfluoroalkyl substances and risk of renal cell carcinoma","volume":"113","author":"Shearer","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"2026093009394949000_bgag051-B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2020.152565","article-title":"Early life exposure to per-and polyfluoroalkyl substances (PFAS) and latent health outcomes: a review including the placenta as a target tissue and possible driver of peri-and postnatal effects","volume":"443","author":"Blake","year":"2020","journal-title":"Toxicol"},{"key":"2026093009394949000_bgag051-B13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s40572-024-00464-5","article-title":"Effects of early-life PFAS exposure on child neurodevelopment: a review of the evidence and research gaps","volume":"12","author":"Ames","year":"2025","journal-title":"Curr Environ Health Rep"},{"key":"2026093009394949000_bgag051-B14","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ijheh.2011.08.011","article-title":"Placental transfer of perfluorinated compounds is selective\u2013a Norwegian mother and child sub-cohort study","volume":"215","author":"G\u00fctzkow","year":"2012","journal-title":"Int J Hyg Environ Health"},{"key":"2026093009394949000_bgag051-B15","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1289\/ehp.10334","article-title":"Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth","volume":"115","author":"Apelberg","year":"2007","journal-title":"Environ Health Perspect"},{"key":"2026093009394949000_bgag051-B16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.envres.2008.06.001","article-title":"Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples","volume":"108","author":"Monroy","year":"2008","journal-title":"Environ Res"},{"key":"2026093009394949000_bgag051-B17","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.chemosphere.2012.08.035","article-title":"Concentrations of perfluoroalkyl compounds in maternal and umbilical cord sera and birth outcomes in Korea","volume":"90","author":"Lee","year":"2013","journal-title":"Chemosphere"},{"key":"2026093009394949000_bgag051-B18","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3390\/toxics9070168","article-title":"Placental transfer and composition of perfluoroalkyl substances (PFASs): a Korean birth panel of parent-infant triads","volume":"9","author":"Kang","year":"2021","journal-title":"Toxics"},{"key":"2026093009394949000_bgag051-B19","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.placenta.2015.07.119","article-title":"Organic anion transporter 4 (OAT 4) modifies placental transfer of perfluorinated alkyl acids PFOS and PFOA in human placental ex vivo perfusion system","volume":"36","author":"Kummu","year":"2015","journal-title":"Placenta"},{"key":"2026093009394949000_bgag051-B20","volume-title":"Toxicological Profile for Perfluoroalkyls","year":"2021"},{"key":"2026093009394949000_bgag051-B21","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.14934","article-title":"Association of early pregnancy perfluoroalkyl and polyfluoroalkyl substance exposure with birth outcomes","volume":"6","author":"Zhang","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026093009394949000_bgag051-B22","doi-asserted-by":"publisher","DOI":"10.1289\/EHP11377","article-title":"Prenatal exposure to PFAS, associations with preterm birth and modification by maternal estrogen levels: the Maoming birth study","volume":"131","author":"Qin","year":"2023","journal-title":"Environ Health Perspect"},{"key":"2026093009394949000_bgag051-B23","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s40572-020-00279-0","article-title":"Perfluoroalkyl substances (PFAS) and their effects on the placenta, pregnancy, and child development: a potential mechanistic role for placental peroxisome proliferator\u2013activated receptors (PPARs)","volume":"7","author":"Szilagyi","year":"2020","journal-title":"Curr Environ Health Rep"},{"key":"2026093009394949000_bgag051-B24","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1016\/j.placenta.2006.12.006","article-title":"Involvement of PPAR\u03b3 in human trophoblast invasion","volume":"28 Suppl A","author":"Fournier","year":"2007","journal-title":"Placenta"},{"key":"2026093009394949000_bgag051-B25","doi-asserted-by":"publisher","first-page":"E1468","DOI":"10.1210\/jc.2012-1064","article-title":"Placental expression of peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3): relation to placental and fetal growth","volume":"97","author":"D\u00edaz","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2026093009394949000_bgag051-B26","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1289\/ehp.9491","article-title":"Exposure of perfluorinated chemicals through lactation: levels of matched human milk and serum and a temporal trend, 1996\u20132004, in Sweden","volume":"115","author":"K\u00e4rrman","year":"2006","journal-title":"Environ Health Perspect"},{"key":"2026093009394949000_bgag051-B27","doi-asserted-by":"publisher","first-page":"7123","DOI":"10.1021\/es101184f","article-title":"Pre-and postnatal exposure to perfluorinated compounds (PFCs)","volume":"44","author":"Fromme","year":"2010","journal-title":"Environ Sci Technol"},{"key":"2026093009394949000_bgag051-B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2021.152446","article-title":"Prenatal and postnatal exposure to emerging and legacy per-\/polyfluoroalkyl substances: levels and transfer in maternal serum, cord serum, and breast milk","volume":"812","author":"Zheng","year":"2022","journal-title":"Sci Total Environ"},{"key":"2026093009394949000_bgag051-B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2025.122436","article-title":"Per-and polyfluoroalkyl substance concentrations during pregnancy and at birth and risk of childhood acute lymphoblastic leukemia","volume":"285","author":"Morimoto","year":"2025","journal-title":"Environ Res"},{"key":"2026093009394949000_bgag051-B30","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.envint.2011.01.011","article-title":"Characterisation of human exposure pathways to perfluorinated compounds\u2014comparing exposure estimates with biomarkers of exposure","volume":"37","author":"Haug","year":"2011","journal-title":"Environ Int"},{"key":"2026093009394949000_bgag051-B31","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/jes.2009.73","article-title":"An assessment of the exposure of Americans to perfluorooctane sulfonate: a comparison of estimated intake with values inferred from NHANES data","volume":"21","author":"Egeghy","year":"2011","journal-title":"J Expo Sci Environ Epidemiol"},{"key":"2026093009394949000_bgag051-B32","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1038\/s41467-023-38710-3","article-title":"Newborn metabolomic signatures of maternal per-and polyfluoroalkyl substance exposure and reduced length of gestation","volume":"14","author":"Taibl","year":"2023","journal-title":"Nat Commun"},{"key":"2026093009394949000_bgag051-B33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12940-022-00958-5","article-title":"Consideration of pathways for immunotoxicity of per-and polyfluoroalkyl substances (PFAS)","volume":"22","author":"Ehrlich","year":"2023","journal-title":"Environ Health"},{"key":"2026093009394949000_bgag051-B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2024.176158","article-title":"Per-and polyfluoroalkyl substances (PFAS) and cancer: detection methodologies, epidemiological insights, potential carcinogenic mechanisms, and future perspectives","volume":"953","author":"Zheng","year":"2024","journal-title":"Sci Total Environ"},{"key":"2026093009394949000_bgag051-B35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0083-6729(05)71004-9","article-title":"Thyroid hormones and brain development","volume":"71","author":"Bernal","year":"2005","journal-title":"Vitam Horm"},{"key":"2026093009394949000_bgag051-B36","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S2213-8587(22)00339-4","article-title":"Molecular basis of normal and pathological puberty: from basic mechanisms to clinical implications","volume":"11","author":"Argente","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026093009394949000_bgag051-B37","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.3390\/cancers14122919","article-title":"Toward a mechanistic understanding of poly-and perfluoroalkylated substances and cancer","volume":"14","author":"Boyd","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2026093009394949000_bgag051-B38","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3390\/molecules28020479","article-title":"How the structure of per-and polyfluoroalkyl substances (PFAS) influences their binding potency to the peroxisome proliferator-activated and thyroid hormone receptors\u2014an in silico screening study","volume":"28","author":"Kowalska","year":"2023","journal-title":"Molecules"},{"key":"2026093009394949000_bgag051-B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154338","article-title":"The role of peroxisome proliferator-activated receptors (PPAR) in immune responses","volume":"114","author":"Christofides","year":"2021","journal-title":"Metabolism"},{"key":"2026093009394949000_bgag051-B40","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jhep.2021.09.039","article-title":"Exposure to environmental contaminants is associated with altered hepatic lipid metabolism in non-alcoholic fatty liver disease","volume":"76","author":"Sen","year":"2022","journal-title":"J Hepatol"},{"key":"2026093009394949000_bgag051-B41","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1186\/s12967-025-06517-z","article-title":"Decoding per-and polyfluoroalkyl substances (PFAS) in hepatocellular carcinoma: a multi-omics and computational toxicology approach","volume":"23","author":"Hong","year":"2025","journal-title":"J Transl Med"},{"key":"2026093009394949000_bgag051-B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2021.151945","article-title":"Tumorigenic activity of alternative per-and polyfluoroalkyl substances (PFAS): mechanistic in vitro studies","volume":"808","author":"Pierozan","year":"2022","journal-title":"Sci Total Environ"},{"key":"2026093009394949000_bgag051-B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e37003","article-title":"Exploring the environmental contamination toxicity and potential carcinogenic pathways of perfluorinated and polyfluoroalkyl substances (PFAS): an integrated network toxicology and molecular docking strategy","volume":"10","author":"Lin","year":"2024","journal-title":"Heliyon"},{"key":"2026093009394949000_bgag051-B44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.envint.2018.03.004","article-title":"An epigenome-wide study of cord blood DNA methylations in relation to prenatal perfluoroalkyl substance exposure: the Hokkaido study","volume":"115","author":"Miura","year":"2018","journal-title":"Environ Int"},{"key":"2026093009394949000_bgag051-B45","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0092-8674(03)01075-4","article-title":"Principles of tumor suppression","volume":"116","author":"Sherr","year":"2004","journal-title":"Cell"},{"key":"2026093009394949000_bgag051-B46","volume-title":"Childhood Cancer","year":"2025"},{"key":"2026093009394949000_bgag051-B47","doi-asserted-by":"publisher","DOI":"10.1097\/EE9.0000000000000365","article-title":"Prenatal exposure to per-and polyfluoroalkyl substances (PFAS) from contaminated water and risk of childhood cancer in California, 2000\u20132015","volume":"9","author":"Binczewski","year":"2025","journal-title":"Environ Epidemiol"},{"key":"2026093009394949000_bgag051-B48","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1093\/jnci\/djad261","article-title":"Maternal serum concentrations of per-and polyfluoroalkyl substances and childhood acute lymphoblastic leukemia","volume":"116","author":"Jones","year":"2024","journal-title":"J Natl Cancer Inst"},{"key":"2026093009394949000_bgag051-B49","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/ijc.35370","article-title":"Exposure to per-and polyfluoroalkyl substances in residential settled dust and risk of childhood acute lymphoblastic leukemia","volume":"157","author":"Metayer","year":"2025","journal-title":"Int J Cancer"},{"key":"2026093009394949000_bgag051-B50","doi-asserted-by":"publisher","first-page":"10.1038\/s41370-026-00891-6","DOI":"10.1038\/s41370-026-00891-6","article-title":"Targeted and non-targeted analyses of per-and polyfluoroalkyl substances in newborn dried blood spots and risk of childhood acute lymphoblastic leukemia","volume":"36","author":"Vieira","year":"2026","journal-title":"J Expo Sci Environ Epidemiol"},{"key":"2026093009394949000_bgag051-B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2023.117435","article-title":"Neonatal per-and polyfluoroalkyl substance exposure in relation to retinoblastoma","volume":"240","author":"Chen","year":"2024","journal-title":"Environ Res"},{"key":"2026093009394949000_bgag051-B52","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1080\/10408444.2025.2546427","article-title":"Evaluating health impacts of exposure to PFAS mixtures: a systematic review of epidemiological studies using mixture methods","volume":"55","author":"Kemp","year":"2025","journal-title":"Crit Rev Toxicol"},{"key":"2026093009394949000_bgag051-B53","volume-title":"Guidelines for the Health Risk Assessment of Chemical Mixtures","year":"2026"},{"key":"2026093009394949000_bgag051-B54","volume-title":"CompTox Chemicals Dashboard","year":"2019"},{"key":"2026093009394949000_bgag051-B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2025.109590","article-title":"Novel and legacy per-and polyfluoroalkyl substances in humans: long-term temporal variability and metabolic perturbations","volume":"201","author":"Chang","year":"2025","journal-title":"Environ Int"},{"key":"2026093009394949000_bgag051-B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2023.117743","article-title":"Estimation of per-and polyfluoroalkyl substances (PFAS) half-lives in human studies: a systematic review and meta-analysis","volume":"242","author":"Rosato","year":"2024","journal-title":"Environ Res"},{"key":"2026093009394949000_bgag051-B57","doi-asserted-by":"publisher","DOI":"10.1289\/EHP6785","article-title":"Serum half-lives for short-and long-chain perfluoroalkyl acids after ceasing exposure from drinking water contaminated by firefighting foam","volume":"128","author":"Xu","year":"2020","journal-title":"Environ Health Perspect"},{"key":"2026093009394949000_bgag051-B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2024.120305","article-title":"PFAS and menopause onset: is it just a matter of reverse causation? Cross-sectional and longitudinal analyses in highly exposed women in the veneto region","volume":"264","author":"Berti","year":"2025","journal-title":"Environ Res"},{"key":"2026093009394949000_bgag051-B59","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1289\/EHP273","article-title":"A study of reverse causation: examining the associations of perfluorooctanoic acid serum levels with two outcomes","volume":"125","author":"Dhingra","year":"2017","journal-title":"Environ Health Perspect"},{"key":"2026093009394949000_bgag051-B60","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1093\/aje\/kwae014","article-title":"Estimating effects of longitudinal and cumulative exposure to PFAS mixtures on early adolescent body composition","volume":"193","author":"Kuiper","year":"2024","journal-title":"Am J Epidemiol"},{"key":"2026093009394949000_bgag051-B61","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.enceco.2025.06.007","article-title":"In utero exposure to per-and polyfluoroalkyl substances and neonatal sex hormone levels: implications of endocrine disrupting effects during critical development windows","volume":"7","author":"Xia","year":"2025","journal-title":"Environ Chem Ecotoxicol"},{"key":"2026093009394949000_bgag051-B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2023.117553","article-title":"Association between exposure to per-and perfluoroalkyl substances (PFAS) and reproductive hormones in human: a systematic review and meta-analysis","volume":"241","author":"Li","year":"2024","journal-title":"Environ Res"},{"key":"2026093009394949000_bgag051-B63","doi-asserted-by":"publisher","DOI":"10.1097\/EE9.0000000000000262","article-title":"Prenatal exposure to perfluoroalkyl substances and inflammatory biomarker concentrations","volume":"7","author":"Palaniyandi","year":"2023","journal-title":"Environ Epidemiol"},{"key":"2026093009394949000_bgag051-B64","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adj7048","article-title":"Uncovering per- and polyfluoroalkyl substances (PFAS) with nontargeted ion mobility spectrometry-mass spectrometry analyses","volume":"9","author":"Kirkwood-Donelson","year":"2023","journal-title":"Sci Adv"},{"key":"2026093009394949000_bgag051-B65","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2407-14-45","article-title":"Inverse association of colorectal cancer prevalence to serum levels of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in a large Appalachian population","volume":"14","author":"Innes","year":"2014","journal-title":"BMC Cancer"},{"key":"2026093009394949000_bgag051-B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2023.139411","article-title":"Per- and polyfluoroalkyl substances and the associated thyroid cancer risk: a case-control study in China","volume":"337","author":"Li","year":"2023","journal-title":"Chemosphere"},{"key":"2026093009394949000_bgag051-B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2024.142461","article-title":"Impacts of PFOS, PFOA and their alternatives on the gut, intestinal barriers and gut-organ axis","volume":"361","author":"Zhang","year":"2024","journal-title":"Chemosphere"},{"key":"2026093009394949000_bgag051-B68","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41571-023-00766-x","article-title":"Gut microbiota in colorectal cancer development and therapy","volume":"20","author":"Wong","year":"2023","journal-title":"Nat Rev Clin Oncol"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/carcin\/article-pdf\/47\/3\/bgag051\/71522940\/bgag051.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/carcin\/article-pdf\/47\/3\/bgag051\/71522940\/bgag051.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:39:54Z","timestamp":1790775594000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article\/doi\/10.1093\/carcin\/bgag051\/8853802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7,7]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgag051","relation":{},"ISSN":["0143-3334","1460-2180"],"issn-type":[{"value":"0143-3334","type":"print"},{"value":"1460-2180","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"bgag051"}}